The bacterial endotoxin test (BET) is an important part of assuring safety of parenteral pharmaceuticals and medical devices that contact blood or cerebrospinal fluid. Endotoxin (in the form of LPS) is a naturally occurring product of bacterial metabolism, most often shed from gram negative bacteria such as E. coli. The most utilized method for detection and quantification of bacterial endotoxin is the Limulus amebocyte lysate (LAL) test. In this webinar, a brief history of the LAL test and why it is such an important part of quality control will be given. The factors that come into play while selecting a test method, determining sampling size, and performing validation of the test method will be explored. Viewers will learn: – A brief history of the LAL test – Why this testing is important – Validation testing – Inhibition/Enhancment – What a testing program looks like – Common complications
This webinar is part of our 2-day live, pharma webinar series “Pharmaceutical Sterility Assurance, Contamination Control, and Extractables & Leachables” which will be held on 30 September and 1 October 2020. These webinars, presented by Expert Advisors from Sterigenics, Nelson Labs and Noxilizer are designed to bring you insights into the latest developments and innovations in Pharma Sterilization (Sterilization technologies & sterility assurance), Extractables & Leachables testing (Instruments & techniques & regulatory requirements), as well as Bacterial Endotoxin testing.
Webinars in this series include:
- Key Elements of a Sterility Assurance Program
- Gamma Radiation & EO/NO2 Sterilization: Concepts & Pharma Applications
- Changing Regulatory Requirements for Extractables & Leachables Testing on Pharmaceutical Packaging Systems
If you have trouble registering for this event in IE, please try Chrome.